Literature DB >> 29427129

Trends in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma Incidence, Vermont 1999-2013.

Adepitan A Owosho1, Rashidah Wiley2, Tessie Stansbury2, Semiu O Gbadamosi3, Jon S Ryder2.   

Abstract

This study examines trends in age-adjusted incidence rates of human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) in comparison to oral cavity proper squamous cell carcinoma (OSCC) in the population of Vermont from 1999 to 2013. Data on cases of oral and pharynx cancers diagnosed in Vermont between 1999 and 2013 were obtained from the Vermont cancer registry. The age-adjusted incidence rates and annual percentage change of HPV-related OPSCC and OSCC were calculated using Joinpoint trend analysis. Four hundred and thirty-one cases of HPV-related OPSCC were diagnosed from 1999 to 2013. Males constituted 83% (P < 0.0001) of the cases and the 6th decade of life marked the highest incidence. The overall age-adjusted incidence rates for HPV-related OPSCC significantly increased (from 2.39 to 3.86 per 100,000, P < 0.0001). In males, it significantly increased (from 3.62 to 6.93 per 100,000, P < 0.0001), while in females it remained stable (from 1.18 to 1.02 per 100,000, P = 0.28) during 1999-2013. The average rate of HPV-related OPSCC significantly increased by 4.4% annually (P = 0.004). In males the average rate significantly increased by 5.3% annually (P = 0.001) and in females the rate increased by 0.37% annually (P = 0.87). In contrast, age-adjusted overall incidence rates for OSCC significantly decreased (from 3.99 to 3.35 per 100,000, P = 0.018). The overall rate of OSCC decreased by 0.96% annually (P = 0.37) and the highest incidence of cases was in the 7th decade of life. In conclusion, there was an increasing trend of HPV-related OPSCC, specifically in males, and there appears to be a decreasing trend of OSCC in Vermont.

Entities:  

Keywords:  HPV; Oral cancer; Oropharyngeal cancer; Oropharynx; Vermont

Mesh:

Year:  2018        PMID: 29427129     DOI: 10.1007/s10900-018-0477-1

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  34 in total

1.  Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study.

Authors:  Moustafa Mourad; Thomas Jetmore; Ameya A Jategaonkar; Sami Moubayed; Erin Moshier; Mark L Urken
Journal:  J Oral Maxillofac Surg       Date:  2017-05-22       Impact factor: 1.895

2.  Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists.

Authors:  James S Lewis; Beth Beadle; Justin A Bishop; Rebecca D Chernock; Carol Colasacco; Christina Lacchetti; Joel Todd Moncur; James W Rocco; Mary R Schwartz; Raja R Seethala; Nicole E Thomas; William H Westra; William C Faquin
Journal:  Arch Pathol Lab Med       Date:  2017-12-18       Impact factor: 5.534

3.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

4.  Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer.

Authors:  Hanna Mellin; Liselotte Dahlgren; Eva Munck-Wikland; Johan Lindholm; Hodjattallah Rabbani; Mina Kalantari; Tina Dalianis
Journal:  Int J Cancer       Date:  2002-11-10       Impact factor: 7.396

5.  Factors Associated with HPV Vaccination in Young Males.

Authors:  Kelli M Fuller; Leslie Hinyard
Journal:  J Community Health       Date:  2017-12

6.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

7.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

8.  Objective assessment of trismus in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT).

Authors:  Adepitan A Owosho; Luciana M Pedreira Ramalho; Haley I Rosenberg; SaeHee K Yom; Esther Drill; Elyn Riedel; C Jillian Tsai; Nancy Y Lee; Joseph M Huryn; Cherry L Estilo
Journal:  J Craniomaxillofac Surg       Date:  2016-06-16       Impact factor: 2.078

Review 9.  Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis.

Authors:  Camille C R Ragin; Emanuela Taioli
Journal:  Int J Cancer       Date:  2007-10-15       Impact factor: 7.396

10.  Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.

Authors:  Martin Steinau; Mona Saraiya; Marc T Goodman; Edward S Peters; Meg Watson; Jennifer L Cleveland; Charles F Lynch; Edward J Wilkinson; Brenda Y Hernandez; Glen Copeland; Maria S Saber; Claudia Hopenhayn; Youjie Huang; Wendy Cozen; Christopher Lyu; Elizabeth R Unger
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

View more
  1 in total

1.  Hippocampus sparing volumetric modulated arc therapy in patients with loco-regionally advanced oropharyngeal cancer.

Authors:  Seung Won Seol; Brian H Lee; Timothy L Sita; Jay Ram Devineni; Tim J Kruser; Sean Sachdev; Michelle Gentile; Irene Helenowski; Bharat B Mittal
Journal:  Phys Imaging Radiat Oncol       Date:  2022-09-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.